CoChat

ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis

Open access
Worzfeld, Thomas, Swiercz, Jakub M., Looso, Mario, Straub, Beate K., Sivaraj, Kishor K., Offermanns, Stefan · 2012 · Journal of Clinical Investigation
Cited by 92

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Diagnosis of metastatic breast cancer is associated with a very poor prognosis.New therapeutic targets are urgently needed, but their development is hampered by a lack of understanding of the mechanisms leading to tumor metastasis.Exemplifying this is the fact that the approximately 30% of all breast cancers overexpressing the receptor tyrosine kinase ErbB-2 are characterized by high metastatic potential and poor prognosis, but the signaling events downstream of ErbB-2 that drive cancer cell invasion and metastasis remain incompletely understood.Here we show that overexpression of ErbB-2 in human breast cancer cell lines leads to phosphorylation and activation of the semaphorin receptor Plexin-B1.This was required for ErbB-2-dependent activation of the pro-metastatic small GTPases RhoA and RhoC and promoted invasive behavior of human breast cancer cells.In a mouse model of ErbB-2-overexpressing breast cancer, ablation of the gene encoding Plexin-B1 strongly reduced the occurrence of metastases.Moreover, in human patients with ErbB-2-overexpressing breast cancer, low levels of Plexin-B1 expression correlated with good prognosis.Our data suggest that Plexin-B1 represents a new candidate therapeutic target for treating patients with ErbB-2-positive breast cancer. Results Overexpression of ErbB-2 results in activation of Plexin-B1 and Rho GTPases.To test whether overexpression of ErbB-2 is sufficient to phosphorylate and activate Plexin-B1, we overexpressed wild-type or constitutively active ErbB-2 in HEK293 cells.This resulted in tyrosine phosphorylation of Plexin-B1 (Figure 1A) as well as in activation of RhoA (Figure 1B) and RhoC (Figure 1D), but not of RhoB (Figure 1C), independent of a Plexin-B1 ligand.Expression of a Plexin-B1 mutant that lacks the intracellular domain blocked RhoA and RhoC activation, indicating that Plexin-B1 signaling is indeed required for RhoA and RhoC activation downstream of ErbB-2 (Figure 1B and Supplemental Figure 1; supplemental material available online with this article; doi:10.1172/JCI60568DS1).In addition to its ability to mediate Rho signaling, Plexin-B1 has been shown to be a GTPase-activating protein (GAP) for R-Ras (29).Consistent with earlier studies showing that R-RasGAP activity is independent of Plexin-B1 phosphorylation by ErbB-2 (18), overexpression of wild-type or Conflict of interest:The authors have declared that no conflict of interest exists.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci60568

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 92

Metadata

Authors
Worzfeld, T., Swiercz, J. M., Looso, M., Straub, B. K., Sivaraj, K. K., & Offermanns, S.
Venue
Journal of Clinical Investigation
Published
2012-04-02
Volume
122
Issue
4
Pages
1296-1305
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2080489428
Cited by
92
References
5
FWCI
3.98
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis. https://app.cochat.ai/papers/10.1172/jci60568
The paper
Worzfeld, T., Swiercz, J. M., Looso, M., Straub, B. K., Sivaraj, K. K., & Offermanns, S. (2012). ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis. Journal of Clinical Investigation. https://doi.org/10.1172/jci60568

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.